Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión) Open Journal Systems
Historia del cáncer de mama / History of breast cancer
Resumen
Resumen
El cáncer de mama representa en la actualidad uno de los problemas de salud pública más grandes en México y en el mundo, pues es la primera causa de muerte por neoplasia en mujeres mayores de 25 años. Los primeros registros estadísticos oficiales en México corresponden al año 1982 y a nivel mundial a 1926. Sin embargo, existen registros de civilizaciones antiguas que denotan su existencia durante milenios. En esta revisión se resume parte de la historia del cáncer de mama, desde los egipcios hasta nuestros días y se incluyen las creencias que se tenían acerca de esta enfermedad, así como las aportaciones de grandes científicos que ayudaron a la comprensión y marcaron el rumbo en la prevención y el tratamiento del cáncer de mama.
Abstract
Breast cancer currently represents one of the largest public health problems in Mexico and in the world, since it is the first cause of death due to neoplasia in women over 25 years. The first official statistical records in Mexico correspond to 1982, and worldwide to 1926. However, records of very ancient civilizations denote their existence for millennia. This review summarizes part of the history of breast cancer, from Egyptians to present day, including beliefs that were held about this disease, as well as contributions of great scientists who helped understanding and marked the course in prevention and treatment of breast cancer.
Palabras clave
Referencias
Bonnabeau RC. The Edwin Smith Papyrus from ancient Egypt. The world’s first surgical treatise. Minn Med. 1985;68(4):27780.
Lukong KE. Understanding breast cancer – The long and winding road. BBA Clin. 2017;7:6477.
Papavramidou N, Papavramidis T, Demetriou T. Ancient Greek and Greco-Roman methods in modern surgical treatment of cancer. Ann Surg Oncol. 2010;17: 6657.
Donegan W. History of breast cancer. In: Winchester DJ, Hudis C, Norton L, ed. Breast cancer. Hamilton, Ontario: BC Decker; 2006:114.
Cancer.org. The History of cancer. American Cancer Society; [sin fecha de actualización]. Disponible en https:// www.cancer.org/cancer/cancer-basics/history-of-cancer. html.
Mandell JB. Bathsheba’s breast Women, cancer and history. J Clin Invest. 2005;115(6):1397.
Olson JS. The History of Cancer: An Annotated Bibliography. New York: Greenwood Press; 1991:77.
Ackerknecht EH. Historical Notes on Cancer. Med Hist. 1958;2(2):1149.
Vasilescu C. [Current problems in surgical oncology: 1. Theoretical models in oncology and their implications in surgical therapy]. [article in Romanian] Chirurgia (Bucur). 2011;106(1):1722.
Halsted WS. The Results of Operations for the Cure of Cancer of the Breast Performed At the Johns Hopkins Hospital From June, 1889, To January, 1894. Ann Surg. 1894;20:497555.
Boyd S. On ouphorectomy in the treatment of cancer. Br Med J. 1897;2:8906.
Beatson GT. On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases. Trans Med Chir Soc Edinb. 1896;15:153-79.
Picard JD. History of mammography. Bull Acad Natl Med. 1998;182:161320.
Lane-Claypon JE. A Further Report on Cancer of the Breast. Reports on Public Health and Medical Subjects. 1926;32:5863.
Wainwright JM. A Comparison of Conditions Associated with Breast cancer in Great Britain and America. Cancer Res. 1931;15:36.
Bergljung L. Sir Geoffrey Keynes 1887-1982. Surgical pioneer, medical historian, humanist. Sven Med Tidskr. 2005;9:14753.
Jensen EV, Jacobson HI, Walf AA, Frye CA. Estrogen action: A historic perspective on the implications of considering alternative approaches. Physiol Behav. 2010;99:15162.
Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat. Rev. Drug Discov. 2003;2:20513.
Ourbodiesourselves.org. History. Our Bodies Ourselves; [sin fecha de actualización]. Disponible en https://www. ourbodiesourselves.org/our-story/history.
Rosenbaum J. Rose Kushner. Jewish Women: A Comprehensive Historical Encyclopedia; 27 February 2009. Disponible en https://jwa.org/encyclopedia/article/kushner-rose.
The Treatment of Primary Breast Cancer: Management of Local Disease. NIH Consens Statement Online 1979;2(5):29-30.
Das M, Miyakawa T, Fox CF, Pruss RM, Aharonov A, Herschman HR. Specific radiolabeling of a cell surface receptor for epidermal growth factor. Proc Natl Acad Sci. 1977;74:27904.
Fisher B. The evolution of paradigms for the management of breast cancer: a personal perspective. Cancer Res. 1992;52:237183.
Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, et al. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature. 1986;319(6050):230-4.
Easton D, Ford D, Peto J. Inherited susceptibility to breast cancer. Cancer Surv. 1993;18:95113.
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378(6559):789-92.
Carlson RW. The History and Mechanism of Action of Fulvestrant. Clin Breast Cancer. 2005;6:S58.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med. 2012;366(2):109-19.
Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-52.
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100(14):8418-23.
Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006;24(36):5652- 7. doi: 10.1200/JCO.2006.06.5664.
Carlson B. Oncotype DX Test Offers Guidance For Women Debating Chemotherapy. Biotechnol Healthc. 2006;3(4):12-4.
Van ‘t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530-6.
Instituto Nacional de Cancerología. Historia. México: INCAN; [sin fecha de actualización]. Disponible en http:// www.incan.salud.gob.mx/interna/nosotros/historia.html.
Allende-López A, Fajardo-Gutiérrez A. Historia del registro de cáncer en México. Rev Med Inst Mex Seguro Soc. 2011; 49 (Supl 1): S2732
Maza-Fernández ME, Vecchi-Martini E. El cáncer de mama en México: Evolución, panorama actual y retos de la sociedad civil. Salud Publica Mex. 2009;51 (Supl 2): S32934.
font-family:"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:
minor-latin;mso-ansi-language:ES;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'>
DOI: https://doi.org/10.24875/RMIMSS.M20000117
Enlaces refback
- No hay ningún enlace refback.